Amittha Wickrema

6.0k total citations
111 papers, 3.9k citations indexed

About

Amittha Wickrema is a scholar working on Hematology, Molecular Biology and Physiology. According to data from OpenAlex, Amittha Wickrema has authored 111 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 45 papers in Molecular Biology and 36 papers in Physiology. Recurrent topics in Amittha Wickrema's work include Erythrocyte Function and Pathophysiology (36 papers), Hematopoietic Stem Cell Transplantation (29 papers) and Acute Myeloid Leukemia Research (18 papers). Amittha Wickrema is often cited by papers focused on Erythrocyte Function and Pathophysiology (36 papers), Hematopoietic Stem Cell Transplantation (29 papers) and Acute Myeloid Leukemia Research (18 papers). Amittha Wickrema collaborates with scholars based in United States, Japan and Canada. Amittha Wickrema's co-authors include Shahab Uddin, MC Bondurant, John D. Crispino, Leonidas C. Platanias, SB Krantz, Koen van Besien, Stephen T. Sawyer, JC Winkelmann, Ganesan Keerthivasan and Sarah M. Jacobs-Helber and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Amittha Wickrema

110 papers receiving 3.9k citations

Peers

Countries citing papers authored by Amittha Wickrema

Since Specialization

Citations

This map shows the geographic impact of Amittha Wickrema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amittha Wickrema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amittha Wickrema more than expected).

Fields of papers citing papers by Amittha Wickrema

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amittha Wickrema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amittha Wickrema. The network helps show where Amittha Wickrema may publish in the future.

Co-authorship network of co-authors of Amittha Wickrema

This figure shows the co-authorship network connecting the top 25 collaborators of Amittha Wickrema. A scholar is included among the top collaborators of Amittha Wickrema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amittha Wickrema. Amittha Wickrema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PU.1-Dependent Enhancer Inhibition Separates Tet2 -Deficient Hematopoiesis from Malignant Transformation 2022 ·Blood Cancer Discovery ·(unknown), Boris Bartholdy, Kith Pradhan, Tushar D. Bhagat, (unknown), (unknown), Victor Thiruthuvanathan, Mario Pujato, (unknown), (unknown), Ross L. Levine, Aaron D. Viny, Amittha Wickrema, Amit Verma, Britta Will	11
2	Heterogeneity of Red Blood Cells: Causes and Consequences 2020 ·Frontiers in Physiology ·Anna Bogdanova, Lars Kaestner, Greta Simionato, Amittha Wickrema, Asya Makhro	30
3	Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks 2019 ·Clinical Cancer Research ·(unknown), Wen-Liang Kuo, (unknown), Gaurav S. Choudhary, Shanisha Gordon-Mitchell, Hui Liu, Tushar D. Bhagat, Kathy L. McGraw, Sandeep Gurbuxani, Alan F. List, Amit Verma, Amittha Wickrema	9
4	Identifying Inherited and Acquired Genetic Factors Involved in Poor Stem Cell Mobilization and Donor-Derived Malignancy 2016 ·Biology of Blood and Marrow Transplantation ·(unknown), (unknown), Barbara Neistadt, Rafael Márquez, Amittha Wickrema, Andrew Artz, Koen van Besien, Richard A. Larson, Ming K. Lee, Jeremy Segal, Mary‐Claire King, Tom Walsh, Akiko Shimamura, Sioḃán Keel, Jane E. Churpek, Lucy A. Godley	32
5	Utilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders 2016 ·Oncotarget ·Karolina Gołąb, Randall Grose, Piotr Trzonkowski, Amittha Wickrema, Martin Tibudan, Natalia Marek-Trzonkowska, (unknown), (unknown), Diane Ostrega, J. Michael Millis, Piotr Witkowski	10
6	The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes 2016 ·Haematologica ·Andrew Artz, Brent R. Logan, Xiaochun Zhu, Görgün Akpek, Rodrigo Martino, Vikas Gupta, Hillard M. Lazarus, Mark R. Litzow, Alison W. Loren, Navneet S. Majhail, Richard T. Maziarz, Philip L. McCarthy, Uday Popat, Wael Saber, Stephen R. Spellman, Olle Ringdén, Amittha Wickrema, Marcelo C. Pasquini, Kenneth R. Cooke	42
7	Nuclear Condensation during Mouse Erythropoiesis Requires Caspase-3-Mediated Nuclear Opening 2016 ·Developmental Cell ·Baobing Zhao, Yang Mei, Matthew J. Schipma, Eric W. Roth, Reiner Bleher, Joshua Z. Rappoport, Amittha Wickrema, Jing Yang, Peng Ji	74
8	IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells 2015 ·Blood ·Carolina Schinke, Orsi Giricz, Weijuan Li, Aditi Shastri, Shanisha Gordon, Laura Barreyro, Tushar D. Bhagat, Sanchari Bhattacharyya, Nandini Ramachandra, Matthias Bartenstein, Andrea Pellagatti, Jacqueline Boultwood, Amittha Wickrema, Yiting Yu, Britta Will, Wei Sheng, Ulrich Steidl, Amit Verma	145
9	Pilot Study of Regulatory T Cell Depletion In The Setting Of Autologous Stem Cell Transplantation For Multiple Myeloma 2014 ·Clinical Lymphoma Myeloma & Leukemia ·Gottfried von Keudell, Cara A. Rosenbaum, Todd M. Zimmerman, Michael R. Bishop, Koen van Besien, (unknown), Amittha Wickrema, Andrzej Jakubowiak, Justin Kline	2
10	Essential Role for the Mnk Pathway in the Inhibitory Effects of Type I Interferons on Myeloproliferative Neoplasm (MPN) Precursors 2013 ·Journal of Biological Chemistry ·Swarna Mehrotra, (unknown), Sonali Joshi, Barbara Kroczyńska, Beata Majchrzak, Brady L. Stein, Brandon McMahon, Jessica K. Altman, Jonathan D. Licht, Darren P. Baker, Elizabeth A. Eklund, Amittha Wickrema, Amit Verma, Eleanor N. Fish, Leonidas C. Platanias	15
11	Distinct functions of erythropoietin and stem cell factor are linked to activation of mTOR kinase signaling pathway in human erythroid progenitors 2012 ·Cytokine ·Renaud Geslain, Shahab Uddin, Hui Liu, Hongmei Jiang, Koen van Besien, Tao Pan, Amittha Wickrema	7
12	Analysis of the kinetics of band 3 diffusion in human erythroblasts during assembly of the erythrocyte membrane skeleton 2010 ·British Journal of Haematology ·Gayani C. Kodippili, (unknown), (unknown), Hui Liu, Amittha Wickrema, Ken Ritchie, Philip S. Low	11
13	Osteopontin Regulates Actin Cytoskeleton and Contributes to Cell Proliferation in Primary Erythroblasts 2008 ·Journal of Biological Chemistry ·(unknown), Ying Zhou, (unknown), Hui Liu, Jodie Ulaszek, (unknown), Li Zhou, Koen van Besien, John D. Crispino, Amit Verma, Philip S. Low, Amittha Wickrema	38
14	Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products 2008 ·Leukemia & lymphoma ·(unknown), Dorie Sher, Theodore Karrison, Partow Kebriaei, (unknown), Yanming Zhang, (unknown), Andrew Artz, Lucy A. Godley, Olatoyosi Odenike, Elizabeth Rich, Laura C. Michaelis, Michael J. Thirman, Amittha Wickrema, Koen van Besien, Richard A. Larson, Wendy Stock	6
15	Safety and outcome after fludarabine–thiotepa–TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies 2003 ·Bone Marrow Transplantation ·Koen van Besien, Steven M. Devine, Amittha Wickrema, (unknown), Kamal Adel Amin, Mohamed Yassine, (unknown), Wendy Stock, David Peace, Farhad Ravandi, (unknown), Tony Cheung, Srinivasan Vijayakumar, Robert S. Hoffman, Jeff Sosman	7
16	Cutting Edge: Activation of the p38 Mitogen-Activated Protein Kinase Signaling Pathway Mediates Cytokine-Induced Hemopoietic Suppression in Aplastic Anemia 2002 ·The Journal of Immunology ·Amit Verma, Dilip K. Deb, Antonella Sassano, Suman Kambhampati, Amittha Wickrema, Shahab Uddin, Mani Mohindru, Koen van Besien, Leonidas C. Platanias	74
17	Regulation of myeloma cell growth through Akt/Gsk3/forkhead signaling pathway 2002 ·Biochemical and Biophysical Research Communications ·(unknown), Shahab Uddin, Dolores Mahmud, (unknown), Donald Lavelle, Maqbool Ahmed, Koen van Besien, Amittha Wickrema	35
18	Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells 2002 ·Oncogene ·Dolores Mahmud, (unknown), Dilip K. Deb, Leonidas C. Platanias, Shahab Uddin, Amittha Wickrema	90
19	Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant 2001 ·Bone Marrow Transplantation ·(unknown), Rachel E. Sanborn, (unknown), Wendy Stock, (unknown), David Peace, Amittha Wickrema, Mohamed Yassine, Kamal Adel Amin, (unknown), (unknown), (unknown), (unknown), Koen van Besien	26
20	Defective expression of the SHP-1 phosphatase in polycythemia vera 1999 ·Experimental Hematology ·Amittha Wickrema, Fei Chen, (unknown), (unknown), Sarfraz Ahmad, Shahab Uddin, Yi-Hsiang Chen, Lawrence Feldman, Wendy Stock, R Hoffman, Leonidas C. Platanias	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact